Improving Hepatitis A and B Vaccinations and Screenings in an Outpatient GI Setting
Author
Wetherington, Kimberly
Abstract
Hepatitis A (HAV) and B (HBV) are highly transmittable, vaccine-preventable infections that can cause chronic infection, increased risk for hepatocellular carcinoma, and cirrhosis. Individuals with chronic liver disease are at an increased risk for developing these complications if infected with either condition. Current national guidelines recommend HAV and HBV screening and vaccination for all individuals with chronic liver disease. Research shows that approximately half of the patients with chronic liver disease are not adequately screened for and vaccinated against HAV and HBV despite these recommendations. A quality improvement project utilizing the Plan Do Study Act (PDSA) cycle was performed in an outpatient gastroenterology clinic setting with the intent of increasing HAV and HBV screenings and vaccinations in patients with chronic liver disease. Components from the 4 Pillars Practice Transformation Program framework, which utilizes evidence-based research to improve vaccination uptake in outpatient settings, were also applied.
Date
2022-07-19
Citation:
APA:
Wetherington, Kimberly.
(July 2022).
Improving Hepatitis A and B Vaccinations and Screenings in an Outpatient GI Setting
(DNP Scholarly Project, East Carolina University). Retrieved from the Scholarship.
(http://hdl.handle.net/10342/10856.)
MLA:
Wetherington, Kimberly.
Improving Hepatitis A and B Vaccinations and Screenings in an Outpatient GI Setting.
DNP Scholarly Project. East Carolina University,
July 2022. The Scholarship.
http://hdl.handle.net/10342/10856.
June 29, 2024.
Chicago:
Wetherington, Kimberly,
“Improving Hepatitis A and B Vaccinations and Screenings in an Outpatient GI Setting”
(DNP Scholarly Project., East Carolina University,
July 2022).
AMA:
Wetherington, Kimberly.
Improving Hepatitis A and B Vaccinations and Screenings in an Outpatient GI Setting
[DNP Scholarly Project]. Greenville, NC: East Carolina University;
July 2022.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Spontaneous Weight Change during Chronic Hepatitis C Treatment: Association with Virologic Response Rates
Alwakeel, Hany R.; Zaghla, Hasan E.; Omar, Nabeel A.; Alashinnawy, Hasan A.; Rewisha, Eman A.; Matarese, Laura E.; Taha, Azza A.; Kandil, Hossam M. (2013)Objective: We examined weight changes during chronic hepatitis C (CHC) therapy and association with virologic response. Methods: Weight changes were compared between subjects achieving rapid, early, and sustained virologic ... -
Birth Cohort Screening for Hepatitis C Virus
Smith, Wendy (2019-07-15)Hepatitis C virus (HCV) has been identified as a global, national, and local public health concern. Leading public health organizations have identified high-risk population groups and have developed screening guidelines. ... -
Impaired T cell-mediated hepatitis in peroxisome proliferator activated receptor alpha (PPARα)-deficient mice
Hines, Ian N.; Kremer, Michael; Moore, Sherri M.; Wheeler, Michael D. (2018-02-15)Background Peroxisome proliferator activated receptor alpha (PPARα), a regulator of enzymes involved in β oxidation, has been reported to influence lymphocyte activation. The purpose of this study was to determine whether ...